Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction
Authors:
Open Access
- 5 November 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Abstract
The presence of disease-specific antigens and autoantibodies in the sera of patients with atherosclerosis-related diseases has been widely reported and is considered to result from inflammation of the arterial wall and the involvement of immune factors. The aim of this study was to identify a novel antibody in patients with ischemic stroke by serological identification of antigens using recombinant cDNA expression cloning from patients who had a transient ischemic attack (TIA). We identified the serpin peptidase inhibitor, clade E member 1 (SERPINE1), as a candidate antigen. The serum anti-SERPINE1 antibody levels quantified using amplified luminescent proximity homogeneous assay-linked immunosorbent assay were significantly higher in patients with ischemic stroke, including those with acute cerebral infarction (aCI), TIA, and chronic cerebral infarction, than in healthy donors. The antibody levels were strongly associated with old age, female sex, and presence of hypertension, diabetes mellitus, and cardiovascular disease. Age and intima-media thickness of the carotid artery were positively correlated with antibody levels, which suggests that SERPINE1 may reflect the progression of atherosclerosis. In a multivariate analysis, SERPINE1 antibody level was an independent predictor of aCI. Thus, the serum levels of anti-SERPINE1 antibody could potentially serve as a biomarker of atherothrombotic infarction.Keywords
Funding Information
- Japan Society for the Promotion of Science (20K17953, 19K09451)
- Japan Science and Technology Agency
This publication has 62 references indexed in Scilit:
- Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomasJournal of Experimental & Clinical Cancer Research, 2012
- Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: The Cardiovascular Risk in Young Finns Study and the Health 2000 SurveyAtherosclerosis, 2012
- Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinomaProteome Science, 2011
- Guidelines for the Primary Prevention of StrokeStroke, 2011
- Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjectsCardiovascular Diabetology, 2011
- REVIEW: Plasminogen Activator Inhibitor‐1 (PAI‐1): A Key Factor Linking Fibrinolysis and Age‐Related Subclinical and Clinical ConditionsCardiovascular Therapeutics, 2010
- Prevalence of Asymptomatic Carotid Atherosclerotic Lesions Detected by High-Resolution Ultrasonography and Its Relation to Cardiovascular Risk Factors in the General Population of a Japanese CityStroke, 1997
- Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Stroke PatientsStroke, 1996
- Plasminogen Activator System in Human Coronary AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Immunology of atherosclerosis: Cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimensClinical Immunology and Immunopathology, 1990